1
|
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
56.72
|
2
|
Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
41.47
|
3
|
Heart disease and stroke statistics--2012 update: a report from the American Heart Association.
|
Circulation
|
2011
|
31.98
|
4
|
Heart disease and stroke statistics--2013 update: a report from the American Heart Association.
|
Circulation
|
2012
|
30.79
|
5
|
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.
|
Circulation
|
2013
|
28.02
|
6
|
Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
26.95
|
7
|
Heart disease and stroke statistics--2015 update: a report from the American Heart Association.
|
Circulation
|
2014
|
22.74
|
8
|
Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force.
|
J Am Coll Cardiol
|
2002
|
16.25
|
9
|
Multiple biomarkers for the prediction of first major cardiovascular events and death.
|
N Engl J Med
|
2006
|
15.60
|
10
|
Vitamin D deficiency and risk of cardiovascular disease.
|
Circulation
|
2008
|
13.39
|
11
|
Obesity and the risk of heart failure.
|
N Engl J Med
|
2002
|
12.58
|
12
|
Genome-wide association study of blood pressure and hypertension.
|
Nat Genet
|
2009
|
11.54
|
13
|
Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010.
|
Lancet
|
2012
|
11.32
|
14
|
The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
|
JAMA
|
2013
|
10.43
|
15
|
Long-term trends in the incidence of and survival with heart failure.
|
N Engl J Med
|
2002
|
10.37
|
16
|
Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
|
Circulation
|
2015
|
10.14
|
17
|
The Third Generation Cohort of the National Heart, Lung, and Blood Institute's Framingham Heart Study: design, recruitment, and initial examination.
|
Am J Epidemiol
|
2007
|
9.90
|
18
|
Arterial stiffness and cardiovascular events: the Framingham Heart Study.
|
Circulation
|
2010
|
9.09
|
19
|
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study.
|
Circulation
|
2004
|
8.80
|
20
|
Lifetime risk for developing congestive heart failure: the Framingham Heart Study.
|
Circulation
|
2002
|
8.49
|
21
|
Changes in arterial stiffness and wave reflection with advancing age in healthy men and women: the Framingham Heart Study.
|
Hypertension
|
2004
|
8.27
|
22
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Am Coll Cardiol
|
2010
|
7.54
|
23
|
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study.
|
Arterioscler Thromb Vasc Biol
|
2003
|
7.47
|
24
|
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study.
|
Lancet
|
2009
|
7.27
|
25
|
Plasma natriuretic peptide levels and the risk of cardiovascular events and death.
|
N Engl J Med
|
2004
|
7.12
|
26
|
Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study.
|
Circulation
|
2003
|
6.83
|
27
|
Obesity and the risk of new-onset atrial fibrillation.
|
JAMA
|
2004
|
6.73
|
28
|
Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association.
|
Circulation
|
2014
|
6.55
|
29
|
C-reactive protein, fibrinogen, and cardiovascular disease prediction.
|
N Engl J Med
|
2012
|
6.39
|
30
|
Executive summary: heart disease and stroke statistics--2012 update: a report from the American Heart Association.
|
Circulation
|
2012
|
6.24
|
31
|
Executive summary: heart disease and stroke statistics--2013 update: a report from the American Heart Association.
|
Circulation
|
2013
|
6.13
|
32
|
Aortic stiffness, blood pressure progression, and incident hypertension.
|
JAMA
|
2012
|
6.01
|
33
|
Association of three genetic loci with uric acid concentration and risk of gout: a genome-wide association study.
|
Lancet
|
2008
|
5.89
|
34
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the american heart association.
|
Circulation
|
2011
|
5.26
|
35
|
Long-term outcomes in individuals with prolonged PR interval or first-degree atrioventricular block.
|
JAMA
|
2009
|
5.22
|
36
|
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study.
|
Circulation
|
2007
|
5.10
|
37
|
The Framingham Heart Study 100K SNP genome-wide association study resource: overview of 17 phenotype working group reports.
|
BMC Med Genet
|
2007
|
5.02
|
38
|
Serum aldosterone and the incidence of hypertension in nonhypertensive persons.
|
N Engl J Med
|
2004
|
4.92
|
39
|
The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis.
|
Lancet
|
2012
|
4.87
|
40
|
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring.
|
JAMA
|
2004
|
4.85
|
41
|
Multiple loci associated with indices of renal function and chronic kidney disease.
|
Nat Genet
|
2009
|
4.78
|
42
|
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study.
|
JAMA
|
2003
|
4.77
|
43
|
Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study.
|
Circulation
|
2008
|
4.69
|
44
|
Incidence and prognosis of syncope.
|
N Engl J Med
|
2002
|
4.69
|
45
|
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation.
|
Circulation
|
2011
|
4.65
|
46
|
Interleukin-6 receptor pathways in coronary heart disease: a collaborative meta-analysis of 82 studies.
|
Lancet
|
2012
|
4.63
|
47
|
A risk score for predicting near-term incidence of hypertension: the Framingham Heart Study.
|
Ann Intern Med
|
2008
|
4.61
|
48
|
Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study.
|
Circulation
|
2013
|
4.60
|
49
|
Local shear stress and brachial artery flow-mediated dilation: the Framingham Heart Study.
|
Hypertension
|
2004
|
4.56
|
50
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
4.56
|
51
|
Impact of obesity on plasma natriuretic peptide levels.
|
Circulation
|
2004
|
4.46
|
52
|
Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study.
|
Am J Respir Crit Care Med
|
2006
|
4.36
|
53
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
|
Circulation
|
2007
|
4.16
|
54
|
Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study.
|
Circulation
|
2003
|
4.09
|
55
|
Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
|
Circulation
|
2005
|
4.08
|
56
|
Common variants in KCNN3 are associated with lone atrial fibrillation.
|
Nat Genet
|
2010
|
3.97
|
57
|
Association of common variants in NPPA and NPPB with circulating natriuretic peptides and blood pressure.
|
Nat Genet
|
2009
|
3.81
|
58
|
National study of physician awareness and adherence to cardiovascular disease prevention guidelines.
|
Circulation
|
2005
|
3.77
|
59
|
Genome-wide association study of PR interval.
|
Nat Genet
|
2010
|
3.73
|
60
|
Meta-analysis identifies six new susceptibility loci for atrial fibrillation.
|
Nat Genet
|
2012
|
3.71
|
61
|
Meta-analysis of genome-wide association studies in >80 000 subjects identifies multiple loci for C-reactive protein levels.
|
Circulation
|
2011
|
3.68
|
62
|
Prevention of heart failure: a scientific statement from the American Heart Association Councils on Epidemiology and Prevention, Clinical Cardiology, Cardiovascular Nursing, and High Blood Pressure Research; Quality of Care and Outcomes Research Interdisciplinary Working Group; and Functional Genomics and Translational Biology Interdisciplinary Working Group.
|
Circulation
|
2008
|
3.56
|
63
|
Relation of disease pathogenesis and risk factors to heart failure with preserved or reduced ejection fraction: insights from the framingham heart study of the national heart, lung, and blood institute.
|
Circulation
|
2009
|
3.55
|
64
|
Gamma glutamyl transferase and metabolic syndrome, cardiovascular disease, and mortality risk: the Framingham Heart Study.
|
Arterioscler Thromb Vasc Biol
|
2006
|
3.48
|
65
|
Natural history of asymptomatic left ventricular systolic dysfunction in the community.
|
Circulation
|
2003
|
3.46
|
66
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
Circulation
|
2004
|
3.39
|
67
|
Incident stroke and mortality associated with new-onset atrial fibrillation in patients hospitalized with severe sepsis.
|
JAMA
|
2011
|
3.34
|
68
|
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham Heart Study.
|
Arch Intern Med
|
2005
|
3.31
|
69
|
Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
|
Circulation
|
2006
|
3.15
|
70
|
Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project.
|
PLoS Genet
|
2011
|
3.07
|
71
|
Validation of an atrial fibrillation risk algorithm in whites and African Americans.
|
Arch Intern Med
|
2010
|
3.05
|
72
|
Framingham Heart Study 100K Project: genome-wide associations for blood pressure and arterial stiffness.
|
BMC Med Genet
|
2007
|
3.04
|
73
|
Framingham Heart Study 100K project: genome-wide associations for cardiovascular disease outcomes.
|
BMC Med Genet
|
2007
|
2.93
|
74
|
Candidate gene association resource (CARe): design, methods, and proof of concept.
|
Circ Cardiovasc Genet
|
2010
|
2.91
|
75
|
Effectiveness-based guidelines for the prevention of cardiovascular disease in women--2011 update: a guideline from the American Heart Association.
|
J Am Coll Cardiol
|
2011
|
2.89
|
76
|
Executive Summary: Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association.
|
Circulation
|
2016
|
2.87
|
77
|
Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study.
|
Stroke
|
2008
|
2.84
|
78
|
Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.
|
Circulation
|
2003
|
2.80
|
79
|
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association.
|
Circulation
|
2017
|
2.76
|
80
|
Systemic inflammation and COPD: the Framingham Heart Study.
|
Chest
|
2007
|
2.74
|
81
|
Long-term trends in myocardial infarction incidence and case fatality in the National Heart, Lung, and Blood Institute's Framingham Heart study.
|
Circulation
|
2009
|
2.63
|
82
|
Incidence and prevalence of atrial fibrillation and associated mortality among Medicare beneficiaries, 1993-2007.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
2.61
|
83
|
2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2010
|
2.58
|
84
|
Relations of plasma total TIMP-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham heart study.
|
Eur Heart J
|
2004
|
2.58
|
85
|
Sleep apnea and markers of vascular endothelial function in a large community sample of older adults.
|
Am J Respir Crit Care Med
|
2003
|
2.51
|
86
|
Cross-sectional relations of peripheral microvascular function, cardiovascular disease risk factors, and aortic stiffness: the Framingham Heart Study.
|
Circulation
|
2005
|
2.49
|
87
|
Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium.
|
J Am Heart Assoc
|
2013
|
2.47
|
88
|
AHA/ACCF secondary prevention and risk reduction therapy for patients with coronary and other atherosclerotic vascular disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology Foundation endorsed by the World Heart Federation and the Preventive Cardiovascular Nurses Association.
|
J Am Coll Cardiol
|
2011
|
2.45
|
89
|
Cross-sectional correlates of increased aortic stiffness in the community: the Framingham Heart Study.
|
Circulation
|
2007
|
2.42
|
90
|
P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
2.39
|
91
|
Mitral annular calcification predicts cardiovascular morbidity and mortality: the Framingham Heart Study.
|
Circulation
|
2003
|
2.39
|
92
|
Atrial fibrillation: current knowledge and future directions in epidemiology and genomics.
|
Circulation
|
2011
|
2.36
|
93
|
Plasma natriuretic peptides for community screening for left ventricular hypertrophy and systolic dysfunction: the Framingham heart study.
|
JAMA
|
2002
|
2.33
|
94
|
Relations of biomarkers of distinct pathophysiological pathways and atrial fibrillation incidence in the community.
|
Circulation
|
2010
|
2.32
|
95
|
Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators.
|
Blood
|
2009
|
2.27
|
96
|
Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study.
|
BMC Med Genet
|
2007
|
2.25
|
97
|
Association of leukocyte telomere length with circulating biomarkers of the renin-angiotensin-aldosterone system: the Framingham Heart Study.
|
Circulation
|
2008
|
2.22
|
98
|
Pulse pressure and risk of new-onset atrial fibrillation.
|
JAMA
|
2007
|
2.20
|
99
|
Resistin, adiponectin, and risk of heart failure the Framingham offspring study.
|
J Am Coll Cardiol
|
2008
|
2.18
|
100
|
Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.
|
Eur Heart J
|
2013
|
2.17
|
101
|
Relations of inflammatory biomarkers and common genetic variants with arterial stiffness and wave reflection.
|
Hypertension
|
2008
|
2.14
|
102
|
Impact of age and sex on plasma natriuretic peptide levels in healthy adults.
|
Am J Cardiol
|
2002
|
2.13
|
103
|
Relations of serum aldosterone to cardiac structure: gender-related differences in the Framingham Heart Study.
|
Hypertension
|
2004
|
2.13
|
104
|
Does job strain increase the risk for coronary heart disease or death in men and women? The Framingham Offspring Study.
|
Am J Epidemiol
|
2004
|
2.12
|
105
|
Genetic variants associated with cardiac structure and function: a meta-analysis and replication of genome-wide association data.
|
JAMA
|
2009
|
2.10
|
106
|
Uromodulin levels associate with a common UMOD variant and risk for incident CKD.
|
J Am Soc Nephrol
|
2009
|
2.10
|
107
|
Hemodynamic correlates of blood pressure across the adult age spectrum: noninvasive evaluation in the Framingham Heart Study.
|
Circulation
|
2010
|
2.07
|
108
|
Large scale replication and meta-analysis of variants on chromosome 4q25 associated with atrial fibrillation.
|
Eur Heart J
|
2009
|
2.06
|
109
|
Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community.
|
Circulation
|
2009
|
2.05
|
110
|
Large-scale genomic studies reveal central role of ABO in sP-selectin and sICAM-1 levels.
|
Hum Mol Genet
|
2010
|
2.05
|
111
|
Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study.
|
Am J Epidemiol
|
2007
|
2.02
|
112
|
Cardiac dysfunction and noncardiac dysfunction as precursors of heart failure with reduced and preserved ejection fraction in the community.
|
Circulation
|
2011
|
2.00
|
113
|
Relation of QRS width in healthy persons to risk of future permanent pacemaker implantation.
|
Am J Cardiol
|
2010
|
1.97
|
114
|
QT interval is a heritable quantitative trait with evidence of linkage to chromosome 3 in a genome-wide linkage analysis: The Framingham Heart Study.
|
Heart Rhythm
|
2005
|
1.96
|
115
|
Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.95
|
116
|
A multi-marker approach to predict incident CKD and microalbuminuria.
|
J Am Soc Nephrol
|
2010
|
1.95
|
117
|
Prognostic utility of novel biomarkers of cardiovascular stress: the Framingham Heart Study.
|
Circulation
|
2012
|
1.95
|
118
|
Association of plasma natriuretic peptide levels with metabolic risk factors in ambulatory individuals.
|
Circulation
|
2007
|
1.93
|
119
|
Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.
|
Hypertension
|
2007
|
1.93
|
120
|
Characteristics of Framingham offspring participants with long-lived parents.
|
Arch Intern Med
|
2007
|
1.91
|
121
|
Independent susceptibility markers for atrial fibrillation on chromosome 4q25.
|
Circulation
|
2010
|
1.90
|
122
|
Burden of rare sarcomere gene variants in the Framingham and Jackson Heart Study cohorts.
|
Am J Hum Genet
|
2012
|
1.90
|
123
|
Relation of brachial and digital measures of vascular function in the community: the Framingham heart study.
|
Hypertension
|
2011
|
1.90
|
124
|
European ancestry as a risk factor for atrial fibrillation in African Americans.
|
Circulation
|
2010
|
1.90
|
125
|
Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study.
|
Circulation
|
2004
|
1.84
|
126
|
The epidemiology of "asymptomatic" left ventricular systolic dysfunction: implications for screening.
|
Ann Intern Med
|
2003
|
1.84
|
127
|
Status of the epidemiology of atrial fibrillation.
|
Med Clin North Am
|
2008
|
1.80
|
128
|
Multiple marker approach to risk stratification in patients with stable coronary artery disease.
|
Eur Heart J
|
2010
|
1.80
|
129
|
Cross-sectional relations of multiple biomarkers from distinct biological pathways to brachial artery endothelial function.
|
Circulation
|
2006
|
1.78
|
130
|
CCL2 polymorphisms are associated with serum monocyte chemoattractant protein-1 levels and myocardial infarction in the Framingham Heart Study.
|
Circulation
|
2005
|
1.76
|
131
|
Longitudinal tracking of left ventricular mass over the adult life course: clinical correlates of short- and long-term change in the framingham offspring study.
|
Circulation
|
2009
|
1.75
|
132
|
Association between familial atrial fibrillation and risk of new-onset atrial fibrillation.
|
JAMA
|
2010
|
1.75
|
133
|
Metabolic syndrome, insulin resistance, and brachial artery vasodilator function in Framingham Offspring participants without clinical evidence of cardiovascular disease.
|
Am J Cardiol
|
2008
|
1.74
|
134
|
Pericardial fat is associated with prevalent atrial fibrillation: the Framingham Heart Study.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.70
|
135
|
Association of parental heart failure with risk of heart failure in offspring.
|
N Engl J Med
|
2006
|
1.69
|
136
|
Evidence-based guidelines for cardiovascular disease prevention in women: 2007 update.
|
J Am Coll Cardiol
|
2007
|
1.69
|
137
|
Assessment of endothelial function using digital pulse amplitude tonometry.
|
Trends Cardiovasc Med
|
2009
|
1.69
|
138
|
Cardiovascular risk factors predictive for survival and morbidity-free survival in the oldest-old Framingham Heart Study participants.
|
J Am Geriatr Soc
|
2005
|
1.68
|
139
|
Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study.
|
Circulation
|
2005
|
1.68
|
140
|
Symptoms and functional status of patients with atrial fibrillation: state of the art and future research opportunities.
|
Circulation
|
2012
|
1.67
|
141
|
Carotid artery atherosclerosis, MRI indices of brain ischemia, aging, and cognitive impairment: the Framingham study.
|
Stroke
|
2009
|
1.66
|
142
|
Multimarker approach to evaluate the incidence of the metabolic syndrome and longitudinal changes in metabolic risk factors: the Framingham Offspring Study.
|
Circulation
|
2007
|
1.65
|
143
|
A meta-analysis of four genome-wide association studies of survival to age 90 years or older: the Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium.
|
J Gerontol A Biol Sci Med Sci
|
2010
|
1.65
|
144
|
Genome-wide association of echocardiographic dimensions, brachial artery endothelial function and treadmill exercise responses in the Framingham Heart Study.
|
BMC Med Genet
|
2007
|
1.65
|
145
|
C-reactive protein, inflammatory conditions, and cardiovascular disease risk.
|
Am J Med
|
2007
|
1.64
|
146
|
Genetics of the Framingham Heart Study population.
|
Adv Genet
|
2008
|
1.62
|
147
|
Epidemiology of left ventricular false tendons: clinical correlates in the Framingham Heart Study.
|
J Am Soc Echocardiogr
|
2009
|
1.62
|
148
|
Correlates of echocardiographic indices of cardiac remodeling over the adult life course: longitudinal observations from the Framingham Heart Study.
|
Circulation
|
2010
|
1.62
|
149
|
Relations of arterial stiffness and endothelial function to brain aging in the community.
|
Neurology
|
2013
|
1.60
|
150
|
Association of oxidative stress, insulin resistance, and diabetes risk phenotypes: the Framingham Offspring Study.
|
Diabetes Care
|
2007
|
1.60
|
151
|
Relations of plasma matrix metalloproteinase-9 to clinical cardiovascular risk factors and echocardiographic left ventricular measures: the Framingham Heart Study.
|
Circulation
|
2004
|
1.59
|
152
|
Evidence-based guidelines for cardiovascular disease prevention in women.
|
J Am Coll Cardiol
|
2004
|
1.59
|
153
|
Genome scan of systemic biomarkers of vascular inflammation in the Framingham Heart Study: evidence for susceptibility loci on 1q.
|
Atherosclerosis
|
2005
|
1.59
|
154
|
Mitral valve prolapse in the general population: the benign nature of echocardiographic features in the Framingham Heart Study.
|
J Am Coll Cardiol
|
2002
|
1.58
|
155
|
Lack of replication in polymorphisms reported to be associated with atrial fibrillation.
|
Heart Rhythm
|
2010
|
1.58
|
156
|
Cardiac index is associated with brain aging: the Framingham Heart Study.
|
Circulation
|
2010
|
1.57
|
157
|
Life-course socioeconomic position and incidence of coronary heart disease: the Framingham Offspring Study.
|
Am J Epidemiol
|
2009
|
1.57
|
158
|
Plasma renin and risk of cardiovascular disease and mortality: the Framingham Heart Study.
|
Eur Heart J
|
2007
|
1.55
|
159
|
AHA/ACCF [corrected] 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association task force on performance measures (writing committee to develop performance measures for primary prevention of cardiovascular disease): developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
Circulation
|
2009
|
1.54
|
160
|
A genome-wide association study of aging.
|
Neurobiol Aging
|
2011
|
1.54
|
161
|
Genome-wide association studies of the PR interval in African Americans.
|
PLoS Genet
|
2011
|
1.53
|
162
|
Marital status, marital strain, and risk of coronary heart disease or total mortality: the Framingham Offspring Study.
|
Psychosom Med
|
2007
|
1.53
|
163
|
Genomic variation associated with mortality among adults of European and African ancestry with heart failure: the cohorts for heart and aging research in genomic epidemiology consortium.
|
Circ Cardiovasc Genet
|
2010
|
1.52
|
164
|
Single-gene mutations and increased left ventricular wall thickness in the community: the Framingham Heart Study.
|
Circulation
|
2006
|
1.51
|
165
|
Common genetic variation in KCNH2 is associated with QT interval duration: the Framingham Heart Study.
|
Circulation
|
2007
|
1.50
|
166
|
Evidence-based guidelines for cardiovascular disease prevention in women. American Heart Association scientific statement.
|
Arterioscler Thromb Vasc Biol
|
2004
|
1.49
|
167
|
Relation of platelet and leukocyte inflammatory transcripts to body mass index in the Framingham heart study.
|
Circulation
|
2010
|
1.47
|
168
|
Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.
|
Nephrol Dial Transplant
|
2010
|
1.46
|
169
|
Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: the Framingham Offspring Study.
|
Diabetes
|
2006
|
1.46
|
170
|
C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study.
|
Circulation
|
2002
|
1.46
|
171
|
Clinical correlates, heritability, and genetic linkage of circulating CD40 ligand in the Framingham Offspring Study.
|
Am Heart J
|
2008
|
1.45
|
172
|
Bayesian meta-analysis of genetic association studies with different sets of markers.
|
Am J Hum Genet
|
2008
|
1.44
|
173
|
Atrial fibrillation among Medicare beneficiaries hospitalized with sepsis: incidence and risk factors.
|
Am Heart J
|
2013
|
1.43
|
174
|
Mitral valve prolapse and atrial septal aneurysm: an evaluation in the Framingham Heart Study.
|
Am J Cardiol
|
2002
|
1.43
|
175
|
Heritability and genetic linkage of plasma natriuretic peptide levels.
|
Circulation
|
2003
|
1.42
|
176
|
Atherosclerotic Vascular Disease Conference: Writing Group I: epidemiology.
|
Circulation
|
2004
|
1.42
|
177
|
Arterial stiffness in mild-to-moderate CKD.
|
J Am Soc Nephrol
|
2009
|
1.41
|
178
|
Long-term alcohol consumption and the risk of atrial fibrillation in the Framingham Study.
|
Am J Cardiol
|
2004
|
1.41
|
179
|
Anger and hostility predict the development of atrial fibrillation in men in the Framingham Offspring Study.
|
Circulation
|
2004
|
1.40
|
180
|
Current perceptions of the epidemiology of atrial fibrillation.
|
Cardiol Clin
|
2009
|
1.38
|
181
|
Tension and anxiety and the prediction of the 10-year incidence of coronary heart disease, atrial fibrillation, and total mortality: the Framingham Offspring Study.
|
Psychosom Med
|
2005
|
1.38
|
182
|
Relations of plasma homocysteine to left ventricular structure and function: the Framingham Heart Study.
|
Eur Heart J
|
2004
|
1.37
|
183
|
Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.
|
Circulation
|
2008
|
1.36
|
184
|
Cross-sectional relations of electrocardiographic QRS duration to left ventricular dimensions: the Framingham Heart Study.
|
J Am Coll Cardiol
|
2005
|
1.35
|
185
|
P wave indices: current status and future directions in epidemiology, clinical, and research applications.
|
Circ Arrhythm Electrophysiol
|
2009
|
1.35
|
186
|
Multiple biomarkers and the risk of incident hypertension.
|
Hypertension
|
2007
|
1.34
|
187
|
Cardiovascular epigenetics: basic concepts and results from animal and human studies.
|
Circ Cardiovasc Genet
|
2010
|
1.33
|
188
|
Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation.
|
Circulation
|
2012
|
1.32
|
189
|
Social networks and inflammatory markers in the Framingham Heart Study.
|
J Biosoc Sci
|
2006
|
1.31
|
190
|
Longitudinal tracking of left atrial diameter over the adult life course: Clinical correlates in the community.
|
Circulation
|
2010
|
1.30
|
191
|
Relation of multiple inflammatory biomarkers to incident atrial fibrillation.
|
Am J Cardiol
|
2009
|
1.28
|
192
|
Genome-wide association studies of atrial fibrillation: past, present, and future.
|
Cardiovasc Res
|
2011
|
1.27
|
193
|
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study).
|
Am J Cardiol
|
2007
|
1.26
|
194
|
Depressive symptoms, coronary heart disease, and overall mortality in the Framingham Heart Study.
|
Psychosom Med
|
2005
|
1.26
|
195
|
Multimarker approach to evaluate correlates of vascular stiffness: the Framingham Heart Study.
|
Circulation
|
2008
|
1.26
|
196
|
Aortic root remodeling over the adult life course: longitudinal data from the Framingham Heart Study.
|
Circulation
|
2010
|
1.25
|
197
|
Health insurance and cardiovascular disease risk factors.
|
Am J Med
|
2010
|
1.25
|
198
|
Antecedent blood pressure, body mass index, and the risk of incident heart failure in later life.
|
Hypertension
|
2007
|
1.24
|
199
|
Relations of exercise blood pressure response to cardiovascular risk factors and vascular function in the Framingham Heart Study.
|
Circulation
|
2012
|
1.23
|
200
|
Endogenous sex hormones and cardiovascular disease incidence in men.
|
Ann Intern Med
|
2006
|
1.22
|
201
|
White blood cell count and risk of incident atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
1.22
|
202
|
Association of educational level with inflammatory markers in the Framingham Offspring Study.
|
Am J Epidemiol
|
2006
|
1.21
|
203
|
CLIA-tested genetic variants on commercial SNP arrays: potential for incidental findings in genome-wide association studies.
|
Genet Med
|
2010
|
1.21
|
204
|
Life course socioeconomic position is associated with inflammatory markers: the Framingham Offspring Study.
|
Soc Sci Med
|
2010
|
1.21
|
205
|
Cross-sectional association of kidney function with valvular and annular calcification: the Framingham heart study.
|
J Am Soc Nephrol
|
2005
|
1.20
|
206
|
Relation of smoking status to a panel of inflammatory markers: the framingham offspring.
|
Atherosclerosis
|
2008
|
1.20
|
207
|
The relation of genetic and environmental factors to systemic inflammatory biomarker concentrations.
|
Circ Cardiovasc Genet
|
2009
|
1.19
|
208
|
Left ventricular mass, blood pressure, and lowered cognitive performance in the Framingham offspring.
|
Hypertension
|
2007
|
1.18
|
209
|
Electrocardiographic QRS duration and the risk of congestive heart failure: the Framingham Heart Study.
|
Hypertension
|
2006
|
1.18
|
210
|
Exercise blood pressure and the risk of incident cardiovascular disease (from the Framingham Heart Study).
|
Am J Cardiol
|
2008
|
1.18
|
211
|
Low serum magnesium and the development of atrial fibrillation in the community: the Framingham Heart Study.
|
Circulation
|
2012
|
1.17
|
212
|
Relation of circulating liver transaminase concentrations to risk of new-onset atrial fibrillation.
|
Am J Cardiol
|
2012
|
1.17
|
213
|
Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study).
|
Am J Cardiol
|
2004
|
1.17
|
214
|
Visceral and subcutaneous adiposity and brachial artery vasodilator function.
|
Obesity (Silver Spring)
|
2009
|
1.17
|
215
|
ACCF/AHA 2009 performance measures for primary prevention of cardiovascular disease in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures (Writing Committee to Develop Performance Measures for Primary Prevention of Cardiovascular Disease) developed in collaboration with the American Academy of Family Physicians; American Association of Cardiovascular and Pulmonary Rehabilitation; and Preventive Cardiovascular Nurses Association: endorsed by the American College of Preventive Medicine, American College of Sports Medicine, and Society for Women's Health Research.
|
J Am Coll Cardiol
|
2009
|
1.16
|
216
|
Multimarker approach for the prediction of heart failure incidence in the community.
|
Circulation
|
2010
|
1.15
|
217
|
Dietary factors and incident atrial fibrillation: the Framingham Heart Study.
|
Am J Clin Nutr
|
2010
|
1.15
|
218
|
Pericardial fat volume correlates with inflammatory markers: the Framingham Heart Study.
|
Obesity (Silver Spring)
|
2009
|
1.14
|
219
|
Relations of biomarkers of extracellular matrix remodeling to incident cardiovascular events and mortality.
|
Arterioscler Thromb Vasc Biol
|
2010
|
1.13
|
220
|
Optimal threshold value for left ventricular hypertrophy in blacks: the Atherosclerosis Risk in Communities study.
|
Hypertension
|
2004
|
1.13
|
221
|
Mitral annular calcification is a predictor for incident atrial fibrillation.
|
Atherosclerosis
|
2004
|
1.13
|
222
|
Relations of serum phosphorus levels to echocardiographic left ventricular mass and incidence of heart failure in the community.
|
Eur J Heart Fail
|
2010
|
1.13
|
223
|
Associations of long-term and early adult atherosclerosis risk factors with aortic and mitral valve calcium.
|
J Am Coll Cardiol
|
2010
|
1.12
|
224
|
Relation of left ventricular ejection fraction to cognitive aging (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
1.12
|
225
|
P-wave indices, distribution and quality control assessment (from the Framingham Heart Study).
|
Ann Noninvasive Electrocardiol
|
2010
|
1.12
|
226
|
Common genetic variation in the 3'-BCL11B gene desert is associated with carotid-femoral pulse wave velocity and excess cardiovascular disease risk: the AortaGen Consortium.
|
Circ Cardiovasc Genet
|
2011
|
1.11
|
227
|
The relation of C--reactive protein to chronic kidney disease in African Americans: the Jackson Heart Study.
|
BMC Nephrol
|
2010
|
1.11
|
228
|
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: executive summary.
|
Circulation
|
2005
|
1.11
|
229
|
A systematic assessment of causes of death after heart failure onset in the community: impact of age at death, time period, and left ventricular systolic dysfunction.
|
Circ Heart Fail
|
2010
|
1.11
|
230
|
Integrating genetic, transcriptional, and functional analyses to identify 5 novel genes for atrial fibrillation.
|
Circulation
|
2014
|
1.11
|
231
|
The role of arrhythmias in defining cardiac dysfunction during sepsis.
|
Am J Respir Crit Care Med
|
2013
|
1.10
|
232
|
Genome-wide association analysis of soluble ICAM-1 concentration reveals novel associations at the NFKBIK, PNPLA3, RELA, and SH2B3 loci.
|
PLoS Genet
|
2011
|
1.10
|
233
|
Epidemiology, heritability, and genetic linkage of C-reactive protein in African Americans (from the Jackson Heart Study).
|
Am J Cardiol
|
2008
|
1.10
|
234
|
Vascular endothelial growth factor, its soluble receptor, and hepatocyte growth factor: clinical and genetic correlates and association with vascular function.
|
Eur Heart J
|
2009
|
1.10
|
235
|
A common connexin-40 gene promoter variant affects connexin-40 expression in human atria and is associated with atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.09
|
236
|
Future directions for cardiovascular disease comparative effectiveness research: report of a workshop sponsored by the National Heart, Lung, and Blood Institute.
|
J Am Coll Cardiol
|
2012
|
1.09
|
237
|
An update on the prognosis of patients with atrial fibrillation.
|
Circulation
|
2012
|
1.09
|
238
|
Relations of biomarkers representing distinct biological pathways to left ventricular geometry.
|
Circulation
|
2008
|
1.09
|
239
|
P wave duration is associated with cardiovascular and all-cause mortality outcomes: the National Health and Nutrition Examination Survey.
|
Heart Rhythm
|
2010
|
1.09
|
240
|
Eight genetic loci associated with variation in lipoprotein-associated phospholipase A2 mass and activity and coronary heart disease: meta-analysis of genome-wide association studies from five community-based studies.
|
Eur Heart J
|
2011
|
1.08
|
241
|
Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: The Framingham Offspring Study.
|
Atherosclerosis
|
2008
|
1.08
|
242
|
Prevalence and prognostic impact of subclinical cardiovascular disease in individuals with the metabolic syndrome and diabetes.
|
Diabetes
|
2007
|
1.08
|
243
|
Relation of season and temperature to endothelium-dependent flow-mediated vasodilation in subjects without clinical evidence of cardiovascular disease (from the Framingham Heart Study).
|
Am J Cardiol
|
2007
|
1.07
|
244
|
Atrial fibrillation in congestive heart failure.
|
Heart Fail Clin
|
2010
|
1.07
|
245
|
Doppler transmitral flow indexes and risk of atrial fibrillation (the Framingham Heart Study).
|
Am J Cardiol
|
2003
|
1.06
|
246
|
Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project.
|
Circ Cardiovasc Genet
|
2011
|
1.06
|
247
|
Relations of circulating resistin and adiponectin and cardiac structure and function: the Framingham Offspring Study.
|
Obesity (Silver Spring)
|
2011
|
1.05
|
248
|
Multiple inflammatory biomarkers in relation to cardiovascular events and mortality in the community.
|
Arterioscler Thromb Vasc Biol
|
2013
|
1.05
|
249
|
Relations of inflammation and novel risk factors to valvular calcification.
|
Am J Cardiol
|
2006
|
1.05
|
250
|
Association of leukocyte telomere length with echocardiographic left ventricular mass: the Framingham heart study.
|
Circulation
|
2009
|
1.04
|
251
|
Reproducibility of speckle-tracking-based strain measures of left ventricular function in a community-based study.
|
J Am Soc Echocardiogr
|
2013
|
1.03
|
252
|
Left ventricular mass indexed to height and prevalent MRI cerebrovascular disease in an African American cohort: the Atherosclerotic Risk in Communities study.
|
Stroke
|
2005
|
1.03
|
253
|
Relations of measures of endothelial function and kidney disease: the Framingham Heart Study.
|
Am J Kidney Dis
|
2008
|
1.03
|
254
|
Association of variation at the ABO locus with circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin: a meta-analysis.
|
Circ Cardiovasc Genet
|
2011
|
1.03
|
255
|
Interleukin 1 receptor 1 and interleukin 1β regulate megakaryocyte maturation, platelet activation, and transcript profile during inflammation in mice and humans.
|
Arterioscler Thromb Vasc Biol
|
2014
|
1.02
|
256
|
Forward and backward wave morphology and central pressure augmentation in men and women in the Framingham Heart Study.
|
Hypertension
|
2014
|
1.02
|
257
|
Genetics of atrial fibrillation: implications for future research directions and personalized medicine.
|
Circ Arrhythm Electrophysiol
|
2010
|
1.01
|
258
|
Association of estrogen receptor beta gene polymorphisms with left ventricular mass and wall thickness in women.
|
Am J Hypertens
|
2005
|
1.00
|
259
|
Clinical and genetic correlates of serum aldosterone in the community: the Framingham Heart Study.
|
Am J Hypertens
|
2005
|
1.00
|
260
|
Mapping quantitative traits in unselected families: algorithms and examples.
|
Genet Epidemiol
|
2009
|
1.00
|
261
|
Association of visceral and subcutaneous adiposity with kidney function.
|
Clin J Am Soc Nephrol
|
2008
|
1.00
|
262
|
Obstructive sleep apnea and plasma natriuretic peptide levels in a community-based sample.
|
Sleep
|
2006
|
0.99
|
263
|
Plasma pyridoxal-5-phosphate is inversely associated with systemic markers of inflammation in a population of U.S. adults.
|
J Nutr
|
2012
|
0.99
|
264
|
Genome-wide scan for pulse pressure in the National Heart, Lung and Blood Institute's Framingham Heart Study.
|
Hypertension
|
2004
|
0.99
|
265
|
Relation of serum leptin with cardiac mass and left atrial dimension in individuals >70 years of age.
|
Am J Cardiol
|
2009
|
0.99
|
266
|
Clinical and echocardiographic correlates of plasma procollagen type III amino-terminal peptide levels in the community.
|
Am Heart J
|
2007
|
0.99
|
267
|
Inflammatory markers and neuropsychological functioning: the Framingham Heart Study.
|
Neuroepidemiology
|
2011
|
0.99
|
268
|
Heritability and correlates of intercellular adhesion molecule-1 in the Framingham Offspring Study.
|
J Am Coll Cardiol
|
2004
|
0.98
|
269
|
Haptoglobin phenotype and prevalent coronary heart disease in the Framingham offspring cohort.
|
Atherosclerosis
|
2004
|
0.98
|
270
|
Electrocardiographic PR interval and adverse outcomes in older adults: the Health, Aging, and Body Composition study.
|
Circ Arrhythm Electrophysiol
|
2012
|
0.98
|
271
|
Relations of matrix remodeling biomarkers to blood pressure progression and incidence of hypertension in the community.
|
Circulation
|
2009
|
0.97
|
272
|
American Heart Association atrial fibrillation research summit: a conference report from the American Heart Association.
|
Circulation
|
2011
|
0.97
|
273
|
Age- and sex-based reference limits and clinical correlates of myocardial strain and synchrony: the Framingham Heart Study.
|
Circ Cardiovasc Imaging
|
2013
|
0.97
|
274
|
Atrial fibrillation is associated with lower cognitive performance in the Framingham offspring men.
|
J Stroke Cerebrovasc Dis
|
2007
|
0.97
|
275
|
Novel risk factors for atrial fibrillation: useful for risk prediction and clinical decision making?
|
Circulation
|
2012
|
0.97
|
276
|
Novel loci associated with PR interval in a genome-wide association study of 10 African American cohorts.
|
Circ Cardiovasc Genet
|
2012
|
0.97
|
277
|
Clinical course of atrial fibrillation in older adults: the importance of cardiovascular events beyond stroke.
|
Eur Heart J
|
2013
|
0.97
|
278
|
Consent for genetic research in the Framingham Heart Study.
|
Am J Med Genet A
|
2010
|
0.96
|
279
|
Circulating ghrelin, leptin, and soluble leptin receptor concentrations and cardiometabolic risk factors in a community-based sample.
|
J Clin Endocrinol Metab
|
2008
|
0.95
|
280
|
Heritability, linkage, and genetic associations of exercise treadmill test responses.
|
Circulation
|
2007
|
0.95
|
281
|
Next steps in cardiovascular disease genomic research--sequencing, epigenetics, and transcriptomics.
|
Clin Chem
|
2011
|
0.95
|
282
|
Addition of inflammatory biomarkers did not improve diabetes prediction in the community: the framingham heart study.
|
J Am Heart Assoc
|
2012
|
0.95
|
283
|
Vascular stiffness and genetic variation at the endothelial nitric oxide synthase locus: the Framingham Heart study.
|
Hypertension
|
2007
|
0.94
|
284
|
Relationship among circulating inflammatory proteins, platelet gene expression, and cardiovascular risk.
|
Arterioscler Thromb Vasc Biol
|
2013
|
0.94
|
285
|
Clinical correlates and heritability of cystatin C (from the Framingham Offspring Study).
|
Am J Cardiol
|
2008
|
0.94
|
286
|
Plasma resistin, adiponectin, and risk of incident atrial fibrillation: the Framingham Offspring Study.
|
Am Heart J
|
2011
|
0.94
|
287
|
Risk assessment for incident heart failure in individuals with atrial fibrillation.
|
Eur J Heart Fail
|
2013
|
0.94
|
288
|
Aspirin use and cardiovascular events in social networks.
|
Soc Sci Med
|
2012
|
0.93
|
289
|
Clinical and genetic factors associated with lipoprotein-associated phospholipase A2 in the Framingham Heart Study.
|
Atherosclerosis
|
2008
|
0.93
|
290
|
Associations of plasma natriuretic peptide, adrenomedullin, and homocysteine levels with alterations in arterial stiffness: the Framingham Heart Study.
|
Circulation
|
2007
|
0.93
|
291
|
Strategies to design and analyze targeted sequencing data: cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium Targeted Sequencing Study.
|
Circ Cardiovasc Genet
|
2014
|
0.93
|
292
|
Lipoprotein phospholipase A2 and cerebral microbleeds in the Framingham Heart Study.
|
Stroke
|
2012
|
0.93
|
293
|
Plasma brain natriuretic peptide levels and blood pressure tracking in the Framingham Heart Study.
|
Hypertension
|
2003
|
0.92
|
294
|
Plasma leptin levels and incidence of heart failure, cardiovascular disease, and total mortality in elderly individuals.
|
Diabetes Care
|
2008
|
0.92
|
295
|
Clinical correlates of change in inflammatory biomarkers: The Framingham Heart Study.
|
Atherosclerosis
|
2013
|
0.92
|
296
|
Association of novel biomarkers of cardiovascular stress with left ventricular hypertrophy and dysfunction: implications for screening.
|
J Am Heart Assoc
|
2013
|
0.92
|
297
|
Brachial artery diameter, blood flow and flow-mediated dilation in sleep-disordered breathing.
|
Vasc Med
|
2009
|
0.92
|
298
|
Clinical correlates of circulating visfatin levels in a community-based sample.
|
Diabetes Care
|
2007
|
0.91
|
299
|
Left ventricular architecture and survival in African-Americans free of coronary heart disease (from the Atherosclerosis Risk in Communities [ARIC] study).
|
Am J Cardiol
|
2007
|
0.90
|
300
|
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Outcomes Writing Group.
|
Circulation
|
2005
|
0.89
|
301
|
Left ventricular structure and systolic function in African Americans: the Atherosclerosis Risk in Communities (ARIC) study.
|
Ethn Dis
|
2004
|
0.89
|
302
|
Vitamin D status is not related to development of atrial fibrillation in the community.
|
Am Heart J
|
2011
|
0.89
|
303
|
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar.
|
J Am Geriatr Soc
|
2013
|
0.88
|
304
|
Atrial fibrillation patterns and risks of subsequent stroke, heart failure, or death in the community.
|
J Am Heart Assoc
|
2013
|
0.88
|
305
|
Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals.
|
Circulation
|
2007
|
0.88
|
306
|
Association of sex hormones, aging, and atrial fibrillation in men: the Framingham Heart Study.
|
Circ Arrhythm Electrophysiol
|
2014
|
0.87
|
307
|
Genome-wide association study of cardiac structure and systolic function in African Americans: the Candidate Gene Association Resource (CARe) study.
|
Circ Cardiovasc Genet
|
2012
|
0.87
|
308
|
Vascular inflammation and sleep disordered breathing in a community-based cohort.
|
Sleep
|
2013
|
0.87
|
309
|
Age-related changes in echocardiographic measurements: association with variation in the estrogen receptor-alpha gene.
|
Hypertension
|
2007
|
0.87
|
310
|
Breastfeeding in infancy and adult cardiovascular disease risk factors.
|
Am J Med
|
2009
|
0.87
|
311
|
Long-term C-reactive protein variability and prediction of metabolic risk.
|
Am J Med
|
2009
|
0.87
|
312
|
P-wave indices: derivation of reference values from the Framingham Heart Study.
|
Ann Noninvasive Electrocardiol
|
2010
|
0.86
|
313
|
Genome-wide and gene-centric analyses of circulating myeloperoxidase levels in the charge and care consortia.
|
Hum Mol Genet
|
2013
|
0.86
|
314
|
Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation.
|
N Engl J Med
|
2013
|
0.86
|
315
|
The association of tumor necrosis factor alpha receptor 2 and tumor necrosis factor alpha with insulin resistance and the influence of adipose tissue biomarkers in humans.
|
Metabolism
|
2009
|
0.86
|
316
|
Association of matrix metalloproteinases with MRI indices of brain ischemia and aging.
|
Neurobiol Aging
|
2009
|
0.86
|
317
|
Thyroid function and left ventricular structure and function in the Framingham Heart Study.
|
Thyroid
|
2010
|
0.85
|
318
|
New-onset atrial fibrillation during hospitalization.
|
J Am Coll Cardiol
|
2014
|
0.85
|
319
|
Reciprocal relations between physical disability, subjective health, and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2013
|
0.85
|
320
|
Thoracic periaortic and visceral adipose tissue and their cross-sectional associations with measures of vascular function.
|
Obesity (Silver Spring)
|
2013
|
0.84
|
321
|
Stroke risk in AF: do AF patterns matter?
|
Eur Heart J
|
2010
|
0.84
|
322
|
Acquisition, Analysis, and Sharing of Data in 2015 and Beyond: A Survey of the Landscape: A Conference Report From the American Heart Association Data Summit 2015.
|
J Am Heart Assoc
|
2015
|
0.84
|
323
|
Prevalence, clinical correlates, and prognosis of discrete upper septal thickening on echocardiography: the Framingham Heart Study.
|
Echocardiography
|
2008
|
0.84
|
324
|
Evaluation of non-synonymous NPPA single nucleotide polymorphisms in atrial fibrillation.
|
Europace
|
2010
|
0.84
|
325
|
Cross-sectional relations of multiple biomarkers representing distinct biological pathways to plasma markers of collagen metabolism in the community.
|
J Hypertens
|
2009
|
0.84
|
326
|
Triggers of MI for the individual and in the community.
|
Lancet
|
2011
|
0.84
|
327
|
Cross-sectional relations of urinary sodium excretion to cardiac structure and hypertrophy. The Framingham Heart Study.
|
Am J Hypertens
|
2004
|
0.83
|
328
|
Insulin resistance and atrial fibrillation (from the Framingham Heart Study).
|
Am J Cardiol
|
2011
|
0.83
|
329
|
Challenges in the classification of atrial fibrillation.
|
Nat Rev Cardiol
|
2010
|
0.83
|
330
|
Is baseline autonomic tone associated with new onset atrial fibrillation?: Insights from the framingham heart study.
|
Ann Noninvasive Electrocardiol
|
2004
|
0.83
|
331
|
Age of natural menopause and atrial fibrillation: the Framingham Heart Study.
|
Am Heart J
|
2012
|
0.83
|
332
|
Association of carotid artery atherosclerosis with circulating biomarkers of extracellular matrix remodeling: the Framingham Offspring Study.
|
J Stroke Cerebrovasc Dis
|
2008
|
0.83
|
333
|
The KCNMB1 E65K variant is associated with reduced central pulse pressure in the community-based Framingham Offspring Cohort.
|
J Hypertens
|
2009
|
0.83
|
334
|
Genome-wide association study of L-arginine and dimethylarginines reveals novel metabolic pathway for symmetric dimethylarginine.
|
Circ Cardiovasc Genet
|
2014
|
0.83
|
335
|
Body fat, body fat distribution, lean body mass and atrial fibrillation and flutter. A Danish cohort study.
|
Obesity (Silver Spring)
|
2014
|
0.83
|
336
|
Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies.
|
BMC Med Genet
|
2008
|
0.83
|
337
|
Common genetic variation at the endothelial nitric oxide synthase locus and relations to brachial artery vasodilator function in the community.
|
Circulation
|
2005
|
0.82
|
338
|
Large multiethnic Candidate Gene Study for C-reactive protein levels: identification of a novel association at CD36 in African Americans.
|
Hum Genet
|
2014
|
0.82
|
339
|
Familial aggregation of left ventricular geometry and association with parental heart failure: the Framingham Heart Study.
|
Circ Cardiovasc Genet
|
2010
|
0.82
|
340
|
Comparison of the prognostic value of left ventricular hypertrophy in African-American men versus women.
|
Am J Cardiol
|
2004
|
0.82
|
341
|
Summary of the American Heart Association's evidence-based guidelines for cardiovascular disease prevention in women.
|
Arterioscler Thromb Vasc Biol
|
2004
|
0.81
|
342
|
Short-term exposure to air pollution and digital vascular function.
|
Am J Epidemiol
|
2014
|
0.81
|
343
|
Atherosclerotic biomarkers and aortic atherosclerosis by cardiovascular magnetic resonance imaging in the Framingham Heart Study.
|
J Am Heart Assoc
|
2013
|
0.81
|
344
|
Sequencing of SCN5A identifies rare and common variants associated with cardiac conduction: Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) Consortium.
|
Circ Cardiovasc Genet
|
2014
|
0.81
|
345
|
Metabolic syndrome and inflammatory biomarkers: a community-based cross-sectional study at the Framingham Heart Study.
|
Diabetol Metab Syndr
|
2012
|
0.81
|
346
|
'Uncrunching' time: medical schools' use of social media for faculty development.
|
Med Educ Online
|
2013
|
0.81
|
347
|
Association between SNP heterozygosity and quantitative traits in the Framingham Heart Study.
|
Ann Hum Genet
|
2009
|
0.81
|
348
|
Left ventricular mechanical function: clinical correlates, heritability, and association with parental heart failure.
|
Eur J Heart Fail
|
2014
|
0.81
|
349
|
Secular trends in echocardiographic left ventricular mass in the community: the Framingham Heart Study.
|
Heart
|
2013
|
0.80
|
350
|
Phenotype-genotype association grid: a convenient method for summarizing multiple association analyses.
|
BMC Genet
|
2006
|
0.80
|
351
|
Aortic root diameter and longitudinal blood pressure tracking.
|
Hypertension
|
2008
|
0.80
|
352
|
Cross-sectional correlates of serum heat shock protein 70 in the community.
|
Am J Hypertens
|
2006
|
0.80
|
353
|
Atrial Fibrillation and Race - A Contemporary Review.
|
Curr Cardiovasc Risk Rep
|
2013
|
0.80
|
354
|
Plasma asymmetric dimethylarginine, L-arginine and left ventricular structure and function in a community-based sample.
|
Atherosclerosis
|
2008
|
0.79
|
355
|
Association of aortic valve calcium detected by electron beam computed tomography with echocardiographic aortic valve disease and with calcium deposits in the coronary arteries and thoracic aorta.
|
Am J Cardiol
|
2004
|
0.79
|
356
|
Genetic mutations as risk predictors of atrial fibrillation recurrence after catheter ablation?
|
J Am Coll Cardiol
|
2010
|
0.78
|
357
|
Genetic loci associated with atrial fibrillation: relation to left atrial structure in the Framingham Heart Study.
|
J Am Heart Assoc
|
2014
|
0.78
|
358
|
Diabetes, gender, and left ventricular structure in African-Americans: the atherosclerosis risk in communities study.
|
Cardiovasc Ultrasound
|
2006
|
0.78
|
359
|
Aortic root remodeling and risk of heart failure in the Framingham Heart study.
|
JACC Heart Fail
|
2013
|
0.78
|
360
|
Early-life antecedents of atrial fibrillation: place of birth and atrial fibrillation-related mortality.
|
Ann Epidemiol
|
2011
|
0.78
|
361
|
Completion of guideline-recommended initial evaluation of atrial fibrillation.
|
Clin Cardiol
|
2012
|
0.77
|
362
|
Circulating angiogenic cell populations, vascular function, and arterial stiffness.
|
Atherosclerosis
|
2011
|
0.77
|
363
|
Cross-sectional relations of lipid concentrations to left ventricular structural attributes.
|
Am J Cardiol
|
2010
|
0.77
|
364
|
Assessing the incremental predictive performance of novel biomarkers over standard predictors.
|
Stat Med
|
2014
|
0.76
|
365
|
Association of parental hypertension with concentrations of select biomarkers in nonhypertensive offspring.
|
Hypertension
|
2008
|
0.76
|
366
|
Early life predictors of atrial fibrillation-related mortality: evidence from the health and retirement study.
|
Health Place
|
2013
|
0.76
|
367
|
2016 AHA/ACC Clinical Performance and Quality Measures for Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures.
|
J Am Coll Cardiol
|
2016
|
0.75
|
368
|
Large-scale genome-wide analysis identifies genetic variants associated with cardiac structure and function.
|
J Clin Invest
|
2017
|
0.75
|
369
|
Where do we come from? Where are we going? Adverse outcomes in catheter ablation for atrial fibrillation.
|
Circ Arrhythm Electrophysiol
|
2014
|
0.75
|
370
|
Reply.
|
J Hypertens
|
2016
|
0.75
|
371
|
Transfer function-derived central pressure and cardiovascular disease events: the Framingham Heart Study.
|
J Hypertens
|
2016
|
0.75
|
372
|
Fifteen Genetic Loci Associated With the Electrocardiographic P Wave.
|
Circ Cardiovasc Genet
|
2017
|
0.75
|
373
|
Global epidemiology of atrial fibrillation.
|
Nat Rev Cardiol
|
2016
|
0.75
|
374
|
Global Health and Cardiovascular Disease.
|
Circulation
|
2015
|
0.75
|
375
|
Atrial fibrillation and death after myocardial infarction: risk marker or causal mediator?
|
Circulation
|
2011
|
0.75
|
376
|
MicroRNA Signature of Cigarette Smoking and Evidence for a Putative Causal Role of MicroRNAs in Smoking-Related Inflammation and Target Organ Damage.
|
Circ Cardiovasc Genet
|
2017
|
0.75
|
377
|
Erratum: Large-scale analyses of common and rare variants identify 12 new loci associated with atrial fibrillation.
|
Nat Genet
|
2017
|
0.75
|